Lawrence J. Hineline - Jan 4, 2016 Form 4/A - Amendment Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role: SVP of Finance CFO
Signature: /s/ Lawrence J. Hineline
Stock symbol: ITCI
Transactions as of: Jan 4, 2016
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 7/7/2023, 06:07 PM
Date Of Original Report: Jan 6, 2016
Next filing: Dec 23, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ITCI	Stock Option (right to buy)	Award	$0	+40.5K		$0.00	40.5K	Jan 4, 2016	Common Stock	40.5K	$53.63	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Stock Option vests as to one third of the shares on January 4, 2017, one third of the shares on January 4, 2018 and one third of the shares on January 4, 2019.

Remarks:

This Form 4/A is being filed solely to correct an error in the number of shares underlying the stock option granted on January 4, 2016. As previously reported, this stock option was exercised in full on June 14, 2023.